Bausch Health Companies Inc
TSX:BHC
Bausch Health Companies Inc
TSX:BHC
Price:
9.64 CAD
-0.1%
Market Closed
Updated:
May 16, 2024
Bausch Health Companies Inc
Research & Development
|
Bausch Health Companies Inc
Research & Development Peer Comparison
Comparables:
WEED
SNDL
CRON
C
CURA
T
TER
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Research & Development
-$612m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-12%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sundial Growers Inc
NASDAQ:SNDL
|
Research & Development
-CA$324k
|
CAGR 3-Years
13%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Research & Development
-$5.8m
|
CAGR 3-Years
34%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
N/A
|
|
C
|
Curaleaf Holdings Inc
CNSX:CURA
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
T
|
Terrascend Corp
CNSX:TER
|
Research & Development
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bausch Health Companies Inc's Research & Development?
Research & Development
-612m
USD
-612m
USD
Based on the financial report for Mar 31, 2024, Bausch Health Companies Inc's Research & Development amounts to -612m USD.
What is Bausch Health Companies Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-12%
-12%
Over the last year, the Research & Development growth was -12%. The average annual Research & Development growth rates for Bausch Health Companies Inc have been -11% over the past three years , -7% over the past five years , and -12% over the past ten years .
You don't have any saved screeners yet
